Heat Seal Tester for Pharmaceutical Packaging: Blister Packs, Pouches, and Sterile Barrier Systems

Pharmaceutical packaging seal failure is a patient safety issue, not just a quality metric. ISO 11607 and USP <1207> require documented seal integrity verification for all sterile device and drug packaging. KHT STH-3A and STH-5 heat seal testers provide the temperature control, data traceability, and ASTM F88 compliance your QC and regulatory teams require.

Pharmaceutical blister pack and sterile pouch heat seal testing station
/images/app-pharmaceutical.svg

Why Pharmaceutical Packaging Seal Integrity Is Non-Negotiable

Every pharmaceutical package is a sterile barrier system. A compromised seal — even a microleak smaller than 250μm — allows pathogen ingress that can render a sterile drug or device non-sterile. FDA and EMA inspections increasingly cite seal integrity failures as a root cause of product recalls. For blister packs, foil-lidded trays, and flexible pouches, heat seal strength testing per ASTM F88 is the foundational QC test that validates seal process parameters and catches process drift before product reaches patients.

ISO 11607 and USP <1207>: Regulatory Requirements for Sterile Barrier Seal Testing

ISO 11607-1/-2 specifies requirements for materials, sterile barrier systems, and manufacturing processes for terminally sterilized medical devices. It requires process validation that includes heat seal process qualification with defined acceptance criteria for seal strength (typically expressed as minimum N/15mm or N/25mm). USP <1207> provides a hierarchy of container closure integrity tests for pharmaceutical products, with physical/chemical test methods (including seal strength per ASTM F88) as a key verification method. KHT STH-3A and STH-5 models are designed to meet both standards.

ASTM F88 Seal Strength Testing Protocol for Pharmaceutical Applications

For pharmaceutical applications, ASTM F88 specimens are typically 25mm wide (vs. 15mm for food applications) to increase sensitivity. Peel angle is typically Technique B (supported) or C (restrained) to prevent specimen stretch. Minimum acceptable seal strength values vary by application: pharmaceutical pouches typically require ≥20N/25mm; blister lidstock typically ≥10N/15mm. The STH-3A gradient model is ideal for process qualification — its 5-position capability maps the full seal window in one run, providing the DOE data required by ISO 11607 process validation protocols.

Recommended KHT STH Models for Pharma Blister and Pouch Seal Testing

For pharmaceutical QC and process qualification, KHT recommends: (1) STH-3A for R&D and process qualification — the 5-position gradient efficiently generates the temperature-seal curve data required by ISO 11607 validation; (2) STH-5 for production QC — touchscreen profiles and automatic data logging support 21 CFR Part 11 audit trails and daily batch release testing. Both models support the seal widths (10mm, 15mm, 25mm), temperature ranges (up to 300°C), and force ranges (0–600N) required for pharmaceutical packaging materials.

Microleaks and Visual QC Failure: Why Automated Testing Is Required

Visual inspection of heat seals detects gross failures but cannot detect microleaks below 250μm — which are below human visual resolution but large enough for pathogen ingress. USP <1207> explicitly states that visual inspection alone is insufficient as a primary container closure integrity test. Automated heat seal strength testing per ASTM F88 provides quantitative data that predicts seal reliability and can be statistically sampled for batch release decisions. Combined with the STH-3A's gradient curve data, you can demonstrate a validated seal window with a defined safety margin above the microleak threshold.

Frequently Asked Questions

Request a Quote for Pharmaceutical Heat Seal Testing

Tell us your packaging material (blister foil grade, pouch film), required standard (ISO 11607 / USP <1207> / ASTM F88), and lab volume. We'll recommend the right STH model.

Get Pharmaceutical Tester Quote